NCT06423976View on ClinicalTrials.gov

Microbiome Molecular Charaterisation

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

October 31, 2038

Study Completion Date

October 31, 2038

Conditions
Prostate Cancer
Interventions
OTHER

Sequencing study

Sequencing of tumour samples for microbiome analysis and molecular charcterisation.

Trial Locations (1)

SM2 5PT

RECRUITING

Institute of Cancer Research/Royal Marsden NHS FT, Sutton

All Listed Sponsors
lead

Institute of Cancer Research, United Kingdom

OTHER